Determination of celecoxib in human plasma and rat microdialysis samples by liquid chromatography tandem mass spectrometry

被引:43
作者
Bräutigam, L
Vetter, G
Tegeder, I
Heinkele, G
Geisslinger, G
机构
[1] Univ Frankfurt Klinikum, Pharmazentrum Frankfurt, D-60590 Frankfurt, Germany
[2] Dr Margarete Fischer Bosch Inst Clin Pharmacol, D-70376 Stuttgart, Germany
来源
JOURNAL OF CHROMATOGRAPHY B | 2001年 / 761卷 / 02期
关键词
microdialysis; determination; celecoxib;
D O I
10.1016/S0378-4347(01)00333-4
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
Methods for the determination of celecoxib in human plasma and rat microdialysis samples using liquid chromatography tandem mass spectrometry are described. Celecoxib and an internal standard were extracted from plasma by solid-phase extraction with C-18 cartridges. Thereafter compounds were separated on a short narrow bore RP C-18 column (30X2 nun). Microdialysis samples did not require extraction and were injected directly using a narrow bore RP C-18 column (70X2 mm). The detection was by a PE Sciex API 3000 mass spectrometer equipped with a turbo ion spray interface. The compounds were detected in the negative ion mode using the mass transitions m/z 380 --> 316 and m/z 366 --> 302 for celecoxib and internal standard, respectively. The assay was validated for human plasma over a concentration range of 0.25-250 ng/ml using 0.2 ml of sample. The assay for microdialysis samples (50 mul) was validated over a concentration range of 0.5-20 ng/ml. The method was utilised to determine pharmacokinetics of celecoxib in human plasma and in rat spinal cord perfusate. (C) 2001 Published by Elsevier Science B.V.
引用
收藏
页码:203 / 212
页数:10
相关论文
共 13 条
  • [1] Selective inhibition of cyclooxygenase (COX)-2 reverses inflammation and expression of COX-2 and interleukin 6 in rat adjuvant arthritis
    Anderson, GD
    Hauser, SD
    McGarity, KL
    Bremer, ME
    Isakson, PC
    Gregory, SA
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 1996, 97 (11) : 2672 - 2679
  • [2] Expression of cyclooxygenase isoforms in the rat spinal cord and their regulation during adjuvant-induced arthritis
    Beiche, F
    Brune, K
    Geisslinger, G
    Goppelt-Struebe, M
    [J]. INFLAMMATION RESEARCH, 1998, 47 (12) : 482 - 487
  • [3] Up-regulation of cyclooxygenase-2 mRNA in the rat spinal cord following peripheral inflammation
    Beiche, F
    Scheuerer, S
    Brune, K
    Geisslinger, G
    GoppeltStruebe, M
    [J]. FEBS LETTERS, 1996, 390 (02): : 165 - 169
  • [4] CYCLOOXYGENASE-1 AND CYCLOOXYGENASE-2 EXPRESSION IN RHEUMATOID SYNOVIAL TISSUES - EFFECTS OF INTERLEUKIN-1-BETA, PHORBOL ESTER, AND CORTICOSTEROIDS
    CROFFORD, LJ
    WILDER, RL
    RISTIMAKI, AP
    SANO, H
    REMMERS, EF
    EPPS, HR
    HLA, T
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 1994, 93 (03) : 1095 - 1101
  • [5] Inhibition of noxious stimulus-induced spinal prostaglandin E2 release by flurbiprofen enantiomers:: A microdialysis study
    Geisslinger, G
    Muth-Selbach, U
    Coste, O
    Vetter, G
    Schrödter, A
    Schaible, HG
    Brune, K
    Tegeder, I
    [J]. JOURNAL OF NEUROCHEMISTRY, 2000, 74 (05) : 2094 - 2100
  • [6] THE EFFECT OF MORPHINE ON FORMALIN-EVOKED BEHAVIOR AND SPINAL RELEASE OF EXCITATORY AMINO-ACIDS AND PROSTAGLANDIN E(2) USING MICRODIALYSIS IN CONSCIOUS RATS
    MALMBERG, AB
    YAKSH, TL
    [J]. BRITISH JOURNAL OF PHARMACOLOGY, 1995, 114 (05) : 1069 - 1075
  • [7] MALMBERG AB, 1995, J NEUROSCI, V15, P2768
  • [8] Acetaminophen inhibits spinal prostaglandin E2 release after peripheral noxious stimulation
    Muth-Selbach, US
    Tegeder, I
    Brune, K
    Geisslinger, G
    [J]. ANESTHESIOLOGY, 1999, 91 (01) : 231 - 239
  • [9] Celecoxib loses its anti-inflammatory efficacy at high doses through activation of NF-κB
    Niederberger, E
    Tegeder, I
    Vetter, G
    Schmidtko, A
    Schmidt, H
    Euchenhofer, C
    Bräutigam, L
    Grösch, S
    Geisslinger, G
    [J]. FASEB JOURNAL, 2001, 15 (07) : 1622 - +
  • [10] Synthesis and biological evaluation of the 1,5-diarylpyrazole class of cyclooxygenase-2 inhibitors: Identification of 4-[5-(4-methylphenyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl]benzenesulfonamide (SC-58635, Celecoxib)
    Penning, TD
    Talley, JJ
    Bertenshaw, SR
    Carter, JS
    Collins, PW
    Docter, S
    Graneto, MJ
    Lee, LF
    Malecha, JW
    Miyashiro, JM
    Rogers, RS
    Rogier, DJ
    Yu, SS
    Anderson, GD
    Burton, EG
    Cogburn, JN
    Gregory, SA
    Koboldt, CM
    Perkins, WE
    Seibert, K
    Veenhuizen, AW
    Zhang, YY
    Isakson, PC
    [J]. JOURNAL OF MEDICINAL CHEMISTRY, 1997, 40 (09) : 1347 - 1365